Conversely, and in line with previous literature, proxied IL-6 inhibition was associated with an increased odds of developing pneumonia (OR 1.21, 95% CI 1.07–1.38) (Fig. 3C & Supplementary Table S5). Here, IL6 is linked to pneumonia.